A core focus of the partnership is building stronger capabilities among eye care professionals, whereby the two organizations will develop and launch specialized training programs designed for doctors and healthcare practitioners working in ophthalmology.
The hospital will roll out in four phases covering technical planning, project management, commissioning, and full operational launch under Apollo’s brand.
The Intracept™ Procedure targets the basivertebral nerve, which carries pain signals from damaged vertebral endplates.
The IMARA–BC initiative targets women aged 40 and above, encouraging them to undergo routine screening so that cancer is detected at stage one or two, when treatment is most effective.
The new facility operates as a fully smart, digital-first outpatient center that connects appointments, consultations, diagnostics, pharmacy services, and follow-up care through integrated digital systems.
The partnership will provide JOOTRH with dedicated advanced facilities, including project-specific space for an Advanced Pathology Lab within the hospital.
The upgraded complex features modern operating theatres, an intensive care unit (ICU), a high-dependency unit (HDU), and dedicated teaching spaces that enhance both patient care and medical training.
The healthcare centre serves more than 70,000 patients annually from across Jerash Governorate and neighboring areas, making it a vital healthcare resource for the region.
The merger is set to complete within the next quarter, pending final regulatory and statutory approvals from the National Company Law Tribunal (NCLT).
Unlike conventional hospital wards, hospotel prioritizes creating an atmosphere that feels less institutional and more welcoming.